AFDO Conference June 9, Mercedes Mota, Director Medical Device, Surgical Care Johnson & Johnson Quality & Compliance Worldwide

Similar documents
RECALL / EVENT INVESTIGATION & PATIENT LOOK BACK

LIVE INTERACTIVE YOUR DESKTOP. Food Recall Process. Cecilia M. Wolyniak Food and Drug Administration Office of Enforcement

Establishing Rules for: Medical Device Reports (803) & Correction and Removal Reports (806)

Public Health Service Food and Drug Administration San Francisco District 1431 Harbor Bay Parkway Alameda, CA Telephone: 510/

POLICY AND PROCEDURE DOCUMENT NAME: Drug Recall Notification Process

Raritan Pharmaceuticals, Inc. 6/20/17

Food Recalls: May 25, 2016 GREENBERG TRAURIG, LLP ATTORNEYS AT LAW Greenberg Traurig, LLP. All rights reserved.

Inspections, Compliance, Enforcement, and Criminal Investigations

Product Recalls. Protecting Public Health. Presented by William Stewart & Thomas DiBruno

Town and Country Compounding and Consultation Services, LLC 10/17/17

Guidelines for Product Recall or Withdrawal

Sandoz Inc. 12-Aug-08

Talon Compounding Pharmacy 10/3/17

Mini Summit XIV: Clinical Trial Disclosure and Results Reporting Liability under FDAAA, Section 801

Suspected Defective Product Report

PIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES

Preparing a US FDA Medical Device 510(K) Submission

Best Practices in FDA 483 and Warning Letter Management and Recovery

Using Recall Data to Assess the 510(k) Process

BEST PRACTICE CHANGE CONTROL : DECIDING WHEN TO SUBMIT A 510(K) FOR A DEVICE CHANGE. Yuan Xu 18- JAN- 2018

Public Health Service Food and Drug Administration Dallas District 4040 North Central Expressway Dallas, Texas

4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch

Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business

ORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies

Border Issues and Statistics: Regulatory Activities. Mr. Robert Deininger Southwest Import Director AFDO San Antonio, Texas

Guidelines for the Recall or Withdrawal of a Medical Product

TSDR Pharmacy Inc. dba brandmd Skin Care 11/9/17

2014 FDA/JIFSAN Food & Nutrition Webinar

The FDA Food Safety Modernization Act: The Key New Requirements

DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Apini$r$iy -tq 5-f

San Diego Compounding Pharmacy 9/25/17

FDA issues final guidance on benefit-risk factors to consider in medical device product availability, compliance, and enforcement decisions

Hieber's Pharmacy 12/5/17

Planning For The FDA s 'Deeming Rule' For E- Cigarettes

TOBACCO PRODUCT OR MEDICAL PRODUCT?

Agency Information Collection Activities; Submission for Office of Management and Budget

Guidance - IDE Early/Expanded Access for Devices

General Wellness: Policy for Low Risk Devices Guidance for Industry and Food and Drug Administration Staff

Overview of FDA Oversight and Enforcement on Drug Compounding

Medical Device Approval and Product Recalls

Responsibilities of Laser Light Show Projector Manufacturers, Dealers, and Distributors; Final Guidance for Industry and FDA.

Final Rules Preventive Controls for Human Food Preventive Controls for Animal Food

Health Authority Abu Dhabi. Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number:

Stonegate Pharmacy LP 11/10/16

Inspections, Compliance, Enforcement, and Criminal Investigations. Central Texas Regional Blood & Tissue Center 07-Nov-03

Rock Solid Nutrition, LLC 12/22/16

Changing practice to support service delivery

FDA Laws & Pharmacy Practice

510(k) submissions. Getting US FDA clearance for your device: Improving

INTRODUCTION TO DRUG LAW AND REGULATION: REGULATION OF DRUG MANUFACTURING

FDA Recalls and Consumer Complaints

cgmp (21 CFR 111) Regulation and Compliance Overview

Responding to a Food Recall

Southern California Section & Western Compendial Discussion Group

Inspections, Compliance, Enforcement, and Criminal Investigations

Inspections, Compliance, Enforcement, and Criminal Investigations

Optimum Bioenergy International Corp. 12/21/17

FDA Laws & Pharmacy Practice

Overview of Dietary Supplement GMP Inspection Trends Quality Session 6

Consistent with Labeling Final Guidance: Implications for Devices

Overview of the Legal Framework for Medical Device Regulation in the United States

Food Additives Program

Slow The Old FDA Entangled in its own bureaucracy Alleged by some to be too friendly with the industry it was supposed to regulate 3 What is the Curre

Guidance for Industry

Safety Evaluation for Substances Directly Added to Food

Effective and Compliance Dates Applicable to Retailers, Manufacturers, Importers, and Distributors of Newly Deemed Tobacco Products

SAMED Position: Reuse of SUDs

Reishi D. International, Inc. 2/6/18

FDA Basics FDA s Import Operations: How FDA Regulates Imported Products

Lopez Gonzalez Santana Corporation dba Domel and dba Dermixx 8/28/17

L A W O F F I C E S HYMAN, PHELPS & MCNAMARA, P.C.

Committed to Environment, Health, & Safety

Shawn Stevens Food Industry Consultant and Lawyer

NOTICE OF INITIATION OF DISQUALIFICATION PROCEEDINGS AND OPPORTUNITY TO EXPLAIN

New England Compounding Center 04-Dec-06

Premarket Notification: Analysis of FDA Recall Data

Allergy Inspection Guide (4/01)

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN

RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS

May 7, Dear Mr. Landa:

WARNING LETTER DEPARTMENT OF HEALTH & HUMAN SERVICES

RECALL INDEX Q1 2018

Availability of FSIS Compliance Guidelines for Allergens and. Ingredients of Public Health Concern: Identification, Prevention

FDA s Food Additives Program

FSMA, FSVP, and FCS. Deborah Attwood May 12, 2016 Global Food Contact 2016

FAO/WHO guide for developing and improving national food recall systems

Pharmaceutical Product Recall Procedures in India, South Africa and China

FSMA & The Dietary Supplements Industry

CERTIFIED MAIL RETURN RECEIPT REQUESTED. Esther Hernandez President United States Blood Bank, Inc NW 95th Avenue Miami, Florida

September 28, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

STATEMENT OF JOSHUA M. SHARFSTEIN, M.D. PRINCIPAL DEPUTY COMMISSIONER U.S. FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES

FDA REGULATION OF DIETARY SUPPLEMENTS AND FOODS

Use of Standards in Substantial Equivalence Determinations

July 27-30, th Annual Meeting of the Poultry Science Association Louisville, Kentucky. Presented at:

April 30, By Electronic Mail

Inspections, Compliance, Enforcement, and Criminal Investigations

Inspections, Compliance, Enforcement, and Criminal Investigations

Guidance for Industry

Transcription:

AFDO Conference June 9, 2009 Mercedes Mota, Director Medical Device, Surgical Care Johnson & Johnson Quality & Compliance Worldwide

Government Agencies

483 observations A violation of the FD&C Act involving a device which might present a risk to health was not reported to FDA. A report of the required information regarding device correction and removal actions was not sent to FDA within 10 days of initiating the correction and removal. The firm failed to identify all lots of products that may present a risk to health.

Warning Letters Our inspection also revealed that your device is misbranded under section 502(t)(2) of the Act, 21 U.S.C. 352(t)(2), in that your firm failed or refused to furnish material or information respecting the device that is required by or under section 519 of the Act, 21 U.S.C. 360i, and 21 CFR Part 806 - Reports of Corrections and Removals regulation. Significant deviations include, but are not limited to, the following : Failure to submit a written report to FDA of any correction or removal of a device initiated by the manufacturer where the correction or removal was initiated to reduce a risk to health posed by the device, or to remedy a violation of the act caused by the device which may present a risk to health, as required by 21 C.F.R. 806.10.

FDA Definitions Recalls are actions taken by a firm to physically remove or correct a violative product. Recalls may be conducted voluntarily, by FDA request, or by FDA order under statutory authority. Removal is defined as the physical removal of a device from its point of use to some other location for repair, modification, adjustment, relabeling, destruction, or inspection. Correction refers to repair, modification, adjustment, relabeling, destruction or inspection without physically removing it.

FDA Definitions Risk to health: defined as a reasonable probability that use of, or exposure to, the product will cause serious adverse health consequences or death; temporary or medically reversible adverse health consequences; or an outcome in which the probability of serious adverse health consequences is remote. Market Withdrawal: occurs when a product has a minor violation that would not be subject to FDA legal action. The firm removes the product from the market or corrects the violation, ex: a product removed due to tampering, without evidence of manufacturing or distribution problems. Medical device safety alert: situations where a medical device may present an unreasonable risk of substantial harm. In some cases, these are also considered recalls.

FDA Recall Classifications Class I: a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. Ex: food with undeclared allergen; defective heart valve. Class II: a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. Ex: less potent drug that is not for lifethreatening treatment. Class III: a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. Ex: defective container; off-taste or off-color; lack of English labeling in a retail food.

FDA Guidance & Regulations 21 CFR Part 7 general requirements and guidance: Product Information Health Hazard assessment Contacts for Recalling Firm Volume of recalled product Responsible Firm Distribution pattern Reason for Recall Recall Strategy 21 CFR Part 806 describes the record and reporting requirements for device manufacturers and importers if the correction or removal was initiated to reduce a risk to health posed by the device or to remedy a violation of the act caused by the device which may present a risk to health. Except if reported under 803 (MDR). 21 CFR Part 810 Medical Device Recall Authority. FDA may issue a mandatory recall order when a manufacturer or importer fails to voluntarily recall a device that is a risk to health.

First Steps Product Issue Identified Investigation Risk Assessment Frequent 5 Probable 4 Occasional 3 Remote 2 Improbable 1 1 2 3 4 Negligible Marginal Critical Intolerable

Decision Process Quality Board CAPA QB quorum evaluates issue More info? More investigation Field action indicated? No Yes Action required? No Follows recall SOP Document rationale

When to notify FDA 21 CFR Part 806 requires a written report of any correction or removal of a device if the action was prompted to reduce a risk to health or remedy a violation of the act caused by the device. Notification of reportable events under 806.10 are required to be submitted within 10 working days of initiating the correction or removal. Records are required to be maintained under 806.20.

Reporting exemptions 806.1 defines when reports are not required Actions taken to improve the performance or quality of a device, but do not reduce the risk to health or remedy a violation of the act Market withdrawals Routine servicing (preventive maintenance; software updates) Previously reported MedWatch Normal stock rotation Stock recovery Routine servicing

Correction or Removal?

Silent Recalls? Technical or Service Bulletins Unanticipated repairs or parts replacement? Software upgrades Updates or bug fixes? Medical Alert Dear user letters Information or alert to avoid potential risk?

J&J Field Action & Regulatory Reporting Removal: The physical removal of a marketed product (in commercial distribution) from the field because it failed to meet product specifications or labeling (including promotional materials) or, failed to perform as intended. Recalls and Market Withdrawals would be examples of Removals. Field Correction: The repair, modification, adjustment, re-labeling, destruction or inspection (including patient monitoring) of a marketed product because it failed to meet product specifications or labeling (including promotional materials) or, failed to perform as intended, without its physical removal from point of use. Some software updates, modifications and fixes may be considered field corrections, also non-routine servicing. Field Alert: Communication voluntarily issued by a manufacturer, distributor or other responsible person to inform health professionals and/or other persons of a situation that may present an unreasonable risk or substantial harm to the public health. It can also apply to potential product nonconformances or failure of a distributed product to meet any its established specifications. Examples would include new warnings or other safety information.

J&J Field Action Severity Classifications Serious (S1) Significant (S2) Marginal (S3) Negligible (S4) Example: Field action is the result of a defective product where there is reasonable probability that the use of or exposure to will result in a serious adverse event. Or if used improperly, contrary to instructions, which may lead to an unsafe condition. Example: Field action is the result of a defective product where the use of, or exposure to may cause temporary harm or where the probability of serious injury is remote. Or if used improperly, contrary to instructions, may temporarily lead to an unsafe condition. Example: Field action is the result of the product being defective and the use of or exposure to will not likely cause harm. Example: Field action which does not involve a defective product or incorrect labeling, such as product exhibits slight discoloration, but still meets specifications or is a situation that involves events outside the control of the company.

Root cause analysis Design Product specifications/methods Process Design & Development Supply Chain Human Factors/Behavioral Equipment/Instrument/Malfunction Supplier Control/Incorrect raw material Others Special circumstances

Examples: Corrections & Removals